Showing results (561-570 of 592) with videos related to

Sort By:
Pageof 60
JCO Precision Oncology|July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision OncologySophia C Kamran, Monica Borges, Jeff Michalski, et al.
Lancet (London, England)|November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialMaura L Gillison, Andy M Trotti, Jonathan Harris, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in VietnamTasnim Hasan, Thach Ngoc Pham, Thu Anh Nguyen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2024
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic CancerLi Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, et al.
The Lancet. Oncology|November 17, 2024
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal CarcinomaAnne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal CarcinomaWai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
Pageof 60